Stuart Milstein
Alnylam Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Genetics, Aging, and Longevity in Model Organisms, Advanced biosensing and bioanalysis techniques, MicroRNA in disease regulation, CRISPR and Genetic Engineering
Most-Cited Works
- → Towards a proteome-scale map of the human protein–protein interaction network(2005)2,996 cited
- → A Map of the Interactome Network of the Metazoan C. elegans(2004)1,651 cited
- → Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing(2014)1,048 cited
- → Therapeutic siRNA silencing in inflammatory monocytes in mice(2011)830 cited
- → QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASE(1992)682 cited
- → A Conserved Checkpoint Pathway Mediates DNA Damage–Induced Apoptosis and Cell Cycle Arrest in C. elegans(2000)515 cited
- → Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation(2017)402 cited
- → Edgetic perturbation models of human inherited disorders(2009)361 cited
- → Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network(2008)315 cited
- → Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates(2018)295 cited